N-Zyme Biomedical Received $2.76 Million NIH Grant
The Newark-based biotech firm secured federal funding to launch a Phase II clinical trial for a novel reflux treatment.
Live Poll
Should government funding prioritize research into new drug treatments for chronic conditions?